Elevated CEA is associated with worse survival in recurrent rectal cancer-Reference-Cited by-同舟云学术

Elevated CEA is associated with worse survival in recurrent rectal cancer

Published:2017-11-18 Issue:62 Volume:8 Page:105936-105941
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Cho Won Kyung¹,Choi Doo Ho¹,Park Hee Chul¹,Park Won¹,Yu Jeong Il¹,Park Young Suk²,Park Joon Oh²,Lim Ho Yeong²,Kang Won Ki²,Kim Hee Cheol³,Cho Yong Beom³,Yun Seong Hyeon³,Lee Woo Yong³

Affiliation:

1. Department of Radiation Oncology, Seoul, Republic of Korea

2. Division of Hematology-Oncology, Department of Medicine, Seoul, Republic of Korea

3. Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting carcinoembryonic antigen-expressing tumors using a novel transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1;Molecular Therapy - Oncolytics;2023-03

2. Tumour Markers in Clinical Use;Current Cancer Biomarkers;2023-01

3. Regorafenib combined with programmed cell death-1 inhibitor against refractory colorectal cancer and the platelet-to-lymphocyte ratio’s prediction on effectiveness;World Journal of Gastrointestinal Oncology;2022-04-15

4. Management of single pulmonary metastases from colorectal cancer: State of the art;World Journal of Gastrointestinal Oncology;2022-04-15

5. On Demand Biosensors for Early Diagnosis of Cancer and Immune Checkpoints Blockade Therapy Monitoring from Liquid Biopsy;Biosensors;2021-12-07